<DOC>
	<DOCNO>NCT01024543</DOCNO>
	<brief_summary>In study hypothesize infusion Angiotensin II improve insulin-induced microvascular dilatation therefore insulin-mediated glucose uptake . Objectives : Does infusion Angiotensin II increase insulin-mediated glucose uptake via enhanced insulin-mediated microvascular function healthy subject ?</brief_summary>
	<brief_title>Role Angiotensin II Insulin-induced Microvascular Activity</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>1.1860 year 2.Caucasian 3.Blood pressure &lt; 140/90 mmHg . 1 . Obesity ( BMI &gt; 27kg/m2 ) 2 . Cardiovascular disease ( stroke , coronary artery disease , peripheral vascular disease , heart failure ) 3 . Impaired glucose tolerance diabetes mellitus accord criterion ADA 4 . Smoking 5 . Alcohol use &gt; 4U/day 6 . Use medication ( antihypertensive drug , lipid lower drug , corticosteroid , NNSAIDs ) 7 . Pregnancy 8 . Wearing contact lens</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Angiotensin II</keyword>
</DOC>